Buchumschlag

Periconceptional Use of Analgesics and Severity of Structural Birth Defects

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Sebastian O. Ekenze, Michelle Huezo‐Garcia, Stephen M. Kerr, Sarah C. Fisher, Eirini Nestoridi, Martha M. Werler
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2026
Schlagworte:	Clinical Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Risk of Opioid Overdose Associated with Concomitant Use of Methadone and Statins
von: Cheng Chen, et al.
Veröffentlicht: (2024)

PharmVar GeneFocus: CYP4F2
von: Pablo Zubiaur, et al.
Veröffentlicht: (2024)

French‐Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Clinical Use of Mavacamten
von: Louis Lebreton, et al.
Veröffentlicht: (2024)

Model‐Informed Assessment of Probability of Phase 3 Success for Ritlecitinib in Patients with Moderate‐to‐Severe Ulcerative Colitis
von: Jessica Wojciechowski, et al.
Veröffentlicht: (2024)

Biomarkers of Drug‐Induced Kidney Injury: Use in Clinical Trials and Recent Examples of Impact on Drug Development
von: Tanja S. Zabka, et al.
Veröffentlicht: (2025)

Concomitant Use of Oral Anticoagulants With Oral Dipeptidyl Peptidase‐4 Inhibitors and Serious Bleeding Events
von: Thanh Phuong Pham Nguyen, et al.
Veröffentlicht: (2024)

Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug–Drug Interactions
von: Jie Shao, et al.
Veröffentlicht: (2024)

Discovering Severe Adverse Reactions From Pharmacokinetic Drug–Drug Interactions Through Literature Analysis and Electronic Health Record Verification
von: Eugene Jeong, et al.
Veröffentlicht: (2024)

Enhancing External Control Arm Analyses through Data Calibration and Hybrid Designs
von: Sebastian Schneeweiss
Veröffentlicht: (2024)

The Use of Real‐World Evidence for Regulatory Decisions in China
von: Jiayue Xu, et al.
Veröffentlicht: (2024)

Home Is Where the Research Is: The Promise of Decentralized Clinical Trials
von: Sarah A. Holstein
Veröffentlicht: (2025)

A Reflection on the Evolution of Antibody‐Based Therapies in Oncology: Trastuzumab as an Exemplar—Commentary on Dijkers et al.
von: Sarah A. Holstein
Veröffentlicht: (2025)

Mapping the Clinical Development Trajectory of Cell and Gene Therapy Products
von: Magdi Elsallab, et al.
Veröffentlicht: (2024)

Major Adverse Cardiac Events with Ondansetron: A Systematic Review
von: Michael Cristian Garcia, et al.
Veröffentlicht: (2025)

Does Changing the Context of Use Change the Value Proposition of CiPA ?
von: Charles T. Benson, et al.
Veröffentlicht: (2026)

Post‐Approval Pediatric Use of Drugs Granted Waivers from Pediatric Testing
von: Ian T.T. Liu, et al.
Veröffentlicht: (2026)

Current Use of Physiologically Based Pharmacokinetic modeling in New Medicinal Product Approvals at EMA
von: Polly Paul, et al.
Veröffentlicht: (2025)

The Open Hand Initiative: Facilitating the Use of Real‐World Evidence in Regulatory Submissions Through Collaboration and Transparency
von: Elodie Baumfeld Andre, et al.
Veröffentlicht: (2024)

Capturing Synergy Holistically in Psychedelic Clinical Trials: Assessing Processes in Addition to Outcomes
von: Terence H.W. Ching, et al.
Veröffentlicht: (2024)

Use of Real‐World Data and Real‐World Evidence in Rare Disease Drug Development: A Statistical Perspective
von: Jie Chen, et al.
Veröffentlicht: (2025)

Contemporary Use of β‐Blockers in Heart Failure Patients With and Without Atrial Fibrillation: A Nationwide Database Analysis
von: Michikazu Nakai, et al.
Veröffentlicht: (2024)

How PBPK Can Help to Understand Old Drugs and Inform their Dosing in Elderly: Amantadine Case Study
von: Olha Shuklinova, et al.
Veröffentlicht: (2024)

A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)‐Hydroxynorketamine in Healthy Volunteers
von: Shruti M. Raja, et al.
Veröffentlicht: (2024)

Use of FDA Expedited Programs and Development Timelines for New Molecular Entity Drug and New Biologic Approvals by Sponsor Experience
von: Kanhai S. Amin, et al.
Veröffentlicht: (2025)

Off‐Label Use of Mycophenolate: Can Real‐World Evidence Fetch Regulatory Approval for Lupus Nephritis and Other Indications?
von: Nisha Sharma, et al.
Veröffentlicht: (2024)

Reply to: “Current Use of PBPK Modeling in New Medicinal Product Approvals at EMA: A Clinical Appraisal of Voclosporin in Lupus Nephritis”
von: Polly Paul, et al.
Veröffentlicht: (2025)

Using Machine Learning to Determine a Suitable Patient Population for Anakinra for the Treatment of COVID‐19 Under the Emergency Use Authorization
von: Qi Liu, et al.
Veröffentlicht: (2024)

Risk of Hypoglycemia Associated With Concomitant Use of Insulin Secretagogues and ACE Inhibitors in Adults With Type 2 Diabetes: A Systematic Review
von: Patricia Y. Chu, et al.
Veröffentlicht: (2024)

Real‐World Outcomes of Pembrolizumab Monotherapy in Metastatic Non‐Small Cell Lung Cancer by Age and Sex: A National Population‐Based Study in Australia
von: Chin Hang Yiu, et al.
Veröffentlicht: (2026)

Selected Acute Safety Events Following the Use of Nirmatrelvir/Ritonavir or Molnupiravir for COVID‐19: A Nationwide Cohort Study in South Korea
von: Ju Hwan Kim, et al.
Veröffentlicht: (2024)

Cystatin C‐based eGFR better predicts renal vancomycin clearance than creatinine‐based eGFR in patients with allogeneic stem cell transplantation
von: Eva‐Maria A. Wansing, et al.
Veröffentlicht: (2025)

Longitudinal Analysis of Manually and Automatically Classified Circulating Tumor Biomarkers and their Prediction of Survival in Metastatic Colorectal Cancer
von: Maddalena Centanni, et al.
Veröffentlicht: (2025)

In the Cradle of Pharmacometric Methodology: Introducing Population PKPD Modeling, Simultaneous Analysis, and the Effect‐Compartment Model—Commentary on Sheiner et al.
von: Mats O. Karlsson
Veröffentlicht: (2025)

Investigational Use of Real‐World Data as a Hybrid Control in Pancreatic Ductal Adenocarcinoma From the Randomized Phase Ib/II MORPHEUS Trial
von: Andrew H. Ko, et al.
Veröffentlicht: (2024)

Use ofCYP2D6Inhibitors withCYP2D6Opioids: Association with Emergency Department Visits for Pain
von: Noor Ahmed Nahid, et al.
Veröffentlicht: (2024)

Comparison of Regression and Categorical Analysis for Pharmacokinetic Data From Renal Impairment Studies
von: Gerald Chun‐To So, et al.
Veröffentlicht: (2025)

Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability
von: Sarah K. Emond, et al.
Veröffentlicht: (2025)

Navigating the Real World: A Scoping Review of Structured Frameworks to Effectively Identify, Evaluate, and Select Real‐World Data Sources for Fit‐for‐Purpose Studies
von: Sonia Zebachi, et al.
Veröffentlicht: (2025)

Leading the Way: Multi‐Drug Resistance Protein (MDR1) and Clinical Pharmacology—Commentary on Kim et al.
von: Kathleen M. Giacomini
Veröffentlicht: (2025)

MRI Provides New Insights Into the Pharmacologic Mechanism of Bisacodyl: A Blueprint for Understanding Intestinal Drug Mechanisms
von: Kathleen M. Giacomini
Veröffentlicht: (2025)